Abstract:Objective To study the roles of regulated upon activation normal T cell expressed and secreted(RANTES) and monocyte cbemoattractant protein-1 (MCP-1) in human immunodeficien- cy virus-1(HIV 1) infected patients.Methods RANTES and MCP-1 in HIV-1 infected patients, including treated and untreated groups,and healthy control group were determined by enzyme-linked immunosorbent assay(ELISA).The recombinant plasmids,hMCP-pcDNA3.1,bRANTES- peDNA3.1 and hMCP/bRANTES-pcDNA3.1,were constructed and transfected into CHO cells to overexpress the corresponding recombinant proteins,whose chemoattract function was then studied. Results The level of RANTES was (164.3±21.3) pg/mL in healthy control group,(1 224.1±62.0) pg/mL in untreated group and (475.3±36.2) pg/mL in treated group.The level of MCP-1 was (90.6±28.5) pg/mL in healthy control group,(335.0±30.3) pg/mL in untreated group and (807.2±62.6) pg/mL in treated group.In HIV-1 infected patients,the levels of RANTES and MCP-1 were significantly increased.After highly active antiretroviral therapy (HAART),the level of RANTES declined,but MCP-1 increased further.Western blot assay revealed that the three recombinant proteins could be recognized by monoclonal antibodies respectively.All of them could chemoattract human peripheral blood mononuclear cells(PBMCs).And the chemoattractant potency of MCP/RANTES fusion protein was stronger.When the recombinant proteins were used with con- centrations as 50,200,400 and 800 pg/mL,respectively,the number of PBMCs chemoattracted by MCP/RANTES fusion protein was 52×10~4/mL,102×10~4/mL,132×10~4/mL and 184×10~4/mL; the number of PBMCs chemoattracted by RANTES was 27×10~4/mL,51×10~4/mL,65×10~4/mL and 96×10~4/mL;the number of PBMCs chemoattracted by MCP-1 was 18×10~4/mL,44×10~4/mL, 54×10~4/mL and 74×10~4/mL.Conclusion RANTES and MCP-1 may both be involved in the HIV infection process and host immunological reaction against HIV.

Study On The Interaction Of Human Immunodeficiency Virus Inhibitor, Trans-Activitor Of Transcription Protein And Ribonucleic Acid System By Capillary Electrophoresis

Study on the Interactions Between Anti-Hiv-1 Active Compounds with Trans-Activation Response RNA by Affinity Capillary Electrophoresis

Studies of binding constants and interaction of drugs to -activation response RNA by capillary electrophoresis

Capillary Zone Electrophoretic Separation of Four Novel Compounds Active Against Human Immunodeficiency Virus Type 1

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency

Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis.

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

Enzyme Hinders HIV-1 Tat Viral Transport and Real-Time Measured with Nanopores

Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA

[Determination of the Binding Constants of Four Anti-Hiv-1 Active Compounds with Bovine Serum Albumin by Capillary Zone Electrophoresis].

Alpha,Alpha-Trehalose Derivatives Bearing Guanidino Groups As Inhibitors to Hiv-1 Tat-Tar Rna Interaction in Human Cells

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Human Immunodeficiency Virus (HIV)-1 Tat Downregulates the Phosphorylation of Recepteur D'origine Nantais (RON) Receptor Tyrosine Kinase Induced by Macrophage-Stimulating Protein

Inhibitory Effects of Human Immunodeficiency Virus Gp120 and Tat on Cpg-A-Induced Inflammatory Cytokines in Plasmacytoid Dendritic Cells

Study on Evaluation of Human Immunodeficiency Virus Reverse Transcriptase Inhibitor by ELISA

Computational identification and analysis of CNP0269688 as a natural product inhibitor disrupting the interaction between the HIV matrix domain and tRNA

Affinity Capillary Electrophoresis: Study of the Binding of HIV-1 Gp 41 with a Membrane Protein (P45) on the Human B Cell Line, Raji

Establishment of a New Screening Method for Anti-Hiv-1 Drugs

Identifying the Molecular Mechanics and Binding Dynamics Characteristics of Potent Inhibitors to HIV‐1 Protease

Malignant hyperthermia: a pharmacogenetic disorder.